tradingkey.logo

AtriCure Inc

ATRC
36.920USD
-0.190-0.51%
收盤 02/09, 16:00美東報價延遲15分鐘
608.64M總市值
虧損本益比TTM

AtriCure Inc

36.920
-0.190-0.51%

關於 AtriCure Inc 公司

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc簡介

公司代碼ATRC
公司名稱AtriCure Inc
上市日期Aug 05, 2005
CEOCarrel (Michael H)
員工數量1300
證券類型Ordinary Share
年結日Aug 05
公司地址7555 Innovation Way
城市MASON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編45040
電話15137554100
網址https://www.atricure.com
公司代碼ATRC
上市日期Aug 05, 2005
CEOCarrel (Michael H)

AtriCure Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
698.94K
-4000.00%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+822.00%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+15401.00%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-5166.00%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-2500.00%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+822.00%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-2452.00%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+5401.00%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+5401.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
698.94K
-4000.00%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+822.00%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+15401.00%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-5166.00%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-2500.00%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+822.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Appendage Management-United states
45.45M
33.85%
Open Ablation - United states
35.59M
26.51%
Pain management
20.84M
83.47%
Open ablation -International
10.85M
43.47%
Appendage management -International
10.17M
40.73%
其他
-97.94M
-128.04%
地區USD
名稱
營收
佔比
United States
109.31M
81.41%
Europe
15.17M
60.77%
Asia
8.08M
32.38%
Other international
1.71M
6.85%
業務
地區
業務USD
名稱
營收
佔比
Appendage Management-United states
45.45M
33.85%
Open Ablation - United states
35.59M
26.51%
Pain management
20.84M
83.47%
Open ablation -International
10.85M
43.47%
Appendage management -International
10.17M
40.73%
其他
-97.94M
-128.04%

股東統計

更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.84%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
其他
61.38%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.84%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
其他
61.38%
股東類型
持股股東
佔比
Investment Advisor
51.78%
Investment Advisor/Hedge Fund
39.96%
Hedge Fund
5.87%
Individual Investor
3.47%
Research Firm
1.65%
Pension Fund
0.75%
Bank and Trust
0.52%
Family Office
0.07%
Insurance Company
0.03%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
505
50.01M
100.59%
-8.38M
2025Q3
520
49.71M
119.25%
-705.98K
2025Q2
524
50.25M
121.23%
-1.55M
2025Q1
527
51.69M
113.33%
-4.41M
2024Q4
514
47.94M
122.38%
-3.05M
2024Q3
505
52.36M
125.18%
-207.95K
2024Q2
494
52.59M
116.92%
+1.07M
2024Q1
500
51.55M
109.93%
-1.63M
2023Q4
498
48.92M
106.78%
+1.54M
2023Q3
486
47.46M
108.31%
+99.25K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
4.83M
9.71%
-65.32K
-1.33%
Sep 30, 2025
Wellington Management Company, LLP
4.29M
8.63%
+322.82K
+8.13%
Sep 30, 2025
AllianceBernstein L.P.
3.56M
7.16%
-15.06K
-0.42%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
6.86%
-34.35K
-1.00%
Sep 30, 2025
Hood River Capital Management LLC
3.05M
6.13%
-15.47K
-0.51%
Sep 30, 2025
Nomura Investment Management Business Trust
2.29M
4.6%
-213.84K
-8.54%
Sep 30, 2025
Champlain Investment Partners, LLC
1.98M
3.98%
-38.54K
-1.91%
Sep 30, 2025
State Street Investment Management (US)
1.26M
2.54%
-9.44K
-0.74%
Sep 30, 2025
Neuberger Berman, LLC
1.19M
2.4%
+1.37K
+0.12%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+9.32K
+0.79%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Health Care Equipment ETF
1.75%
Harbor Human Capital Factor US Small Cap ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.44%
Fidelity Enhanced Small Cap ETF
0.33%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.17%
查看更多
State Street SPDR S&P Health Care Equipment ETF
佔比1.75%
Harbor Human Capital Factor US Small Cap ETF
佔比0.7%
Invesco NASDAQ Future Gen 200 ETF
佔比0.5%
First Trust Small Cap Growth AlphaDEX Fund
佔比0.44%
Fidelity Enhanced Small Cap ETF
佔比0.33%
Amplify Etho Climate Leadership U.S. ETF
佔比0.3%
Franklin US Small Cap Multifactor Index ETF
佔比0.25%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.24%
iShares U.S. Medical Devices ETF
佔比0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.17%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI